Fresenius Kabi Indonesia is primarily engaged in medicinal chemicals activity. Its headquarters is located in Dki Jakarta. The company was founded in 2006. Fresenius Kabi Indonesia is a subsidiary of Fresenius Kabi, a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The parent company, Fresenius Kabi, is headquartered in Bad Homburg, Germany, and operates in over 100 countries worldwide. Fresenius Kabi Indonesia focuses on providing high-quality pharmaceutical products and medical devices to healthcare professionals and patients across Indonesia. The company's primary business lines include the production and distribution of generic pharmaceuticals, infusion therapies, and clinical nutrition products. Secondary business lines involve the supply of medical devices and transfusion technology. The company operates several branches across Indonesia, ensuring a strong local presence and efficient distribution network. Fresenius Kabi Indonesia is committed to improving patient care and enhancing the quality of life through its innovative products and services. Fresenius Kabi Indonesia collaborates with various healthcare institutions and organizations to support medical education and research initiatives. The company is a member of several industry associations, contributing to the development of healthcare standards and practices in Indonesia. With a focus on sustainability and corporate responsibility, Fresenius Kabi Indonesia aims to deliver safe and effective healthcare solutions while minimizing its environmental impact. The company's mission is to improve the health and well-being of patients by providing reliable and innovative healthcare products and services.
Headquarters
Kav 71-73
South Jakarta; Jakarta;
Postal Code: 12870
Contact Details: Purchase the PT Fresenius Kabi Indonesia report to view the information.
Website: http://www.fresenius-kabi.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service